That sucking sound? Layoffs draining brains from pharma

Tens of thousands of pharma layoffs have left highly qualified employees--from scientists to marketing specialists to finance whizzes--without jobs. "I think we're losing so much expertise," one pharma recruiter said. Report

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.